Bostoen T

ARQ National Psychotrauma Center, Diemen, the Netherlands.

6 papers

ArticleKetamine

Reply to 'Methodological concerns and interpretative limitations of assessing subjective effects of ketamine'.

Dahan JDC, Dadiomov D, Bostoen T +1

Europe PMC2026
ArticlePsilocybin

Post-traumatic stress disorder in psychedelic research.

Bostoen T, Tap S, Breeksema J +1

Europe PMC2025
ArticlePsilocybin

Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.

Tap S, Bostoen T, Breeksema J +1

Europe PMC2025
ArticlePsilocybin

Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome.

Dahan JDC, Dadiomov D, Bostoen T +1

Europe PMC2024
ArticlePsilocybin

Reviewing the Potential of Psychedelics for the Treatment of PTSD.

Krediet E, Bostoen T, Breeksema J +3

Europe PMC2020
ArticlePsilocybin

[Psychedelics in the treatment of PTSD].

Vermetten E, Krediet E, Bostoen T +3

Europe PMC2020